All terms in NCIT
| Label | Id | Description |
|---|---|---|
| MMSE-2 Standard Version - Keep Subtracting 7 Step 5 | NCIT_C151014 | [Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Keep going [65].] |
| MMSE-2 Standard Version - Naming Object 1 | NCIT_C151015 | [Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) What is this: Object 1?] |
| MMSE-2 Standard Version - Recall Word 3 | NCIT_C151009 | [Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) What were those three words I asked you to remember: Word 3?] |
| Calcification Indicator | NCIT_C126056 | [A textual indication as to whether calcification is present.] |
| Percent Change From Nadir in Sum of Area | NCIT_C126057 | [The most recently recorded sum of areas minus the lowest sum of diameters previously recorded divided by the lowest sum of areas previously recorded, multiplied by 100.] |
| Mass Measurement | NCIT_C112025 | |
| Biospecimen Retained and/or Contains DNA Indicator | NCIT_C126058 | [An indication as to whether biospecimens have been retained and/or whether those retained biospecimens contain DNA.] |
| EMA Decision Number for Pediatric Investigation Plan | NCIT_C126059 | [An alphnumeric code assigned by the European Medicines Agency (EMA) to an EMA regulatory decision.] |
| Number of Groups or Cohorts | NCIT_C126063 | [The number of groups or cohorts that are part of the study.] |
| Observational Model | NCIT_C126064 | [The trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals.] |
| Clinical Trials Design | NCIT_C15787 | [The detailed planning of studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects.] |
| Observational Time Perspective of Study | NCIT_C126065 | [The temporal relationship between the observation period and time of subject enrollment. (ClinicalTrials.gov)] |
| Observational Study Population Description | NCIT_C126066 | [A textual description of the population group from which the group or cohort will be selected for observational studies.] |
| MMSE-2 Standard Version - What Is the Day of Week | NCIT_C151000 | [Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) What is the day of the week?] |
| EudraCT Resubmission Indicator | NCIT_C126060 | [An indication as to whether the trial being submitted to the EudraCT is a trial that has been previously submitted to the EudraCT system and withdrawn.] |
| EudraVigilance Sender Identifier | NCIT_C126061 | [A unique identifier assigned to the organization that is transmitting an adverse drug reaction report to the EudraVigilance system.] |
| Protocol Keyword | NCIT_C126062 | [A word or small set of words designed to convey the subject of a clinical study.] |
| Keyword | NCIT_C43513 | [A word or small set of words designed to convey the subject of a technical article.] |
| MMSE-2 Standard Version - What Is the Building | NCIT_C151005 | [Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Where are we now? What is the building (name or type)?] |
| MMSE-2 Standard Version - What Is the Floor | NCIT_C151006 | [Mini-Mental State Examination 2 Standard Version (MMSE-2 Standard Version) Where are we now? What is the floor of the building (room number or address)?] |